ROS-responsive liposomes with NIR light-triggered doxorubicin release for combinatorial therapy of breast cancer

ROS-responsive liposomes with NIR light-triggered doxorubicin release for combinatorial therapy of breast cancer

Abstract Background Reactive oxygen species (ROS)-responsive drug delivery systems (DDSs) are potential tools to minimize the side effects and substantially enhance the therapeutic efficacy of chemotherapy. However, it is challenging to achieve spatially and temporally controllable and accurate drug...

Full description

Bibliographic Details
Main Authors: Hanxi Yi, Wangxing Lu, Fan Liu, Guoqing Zhang, Feifan Xie, Wenjie Liu, Lei Wang, Wenhu Zhou, Zeneng Cheng
Format: Article
Language:English
Published: BMC 2021-05-01
Series:Journal of Nanobiotechnology
Subjects:
Reactive oxygen species response
Prodrug
Synergistic therapy
Photodynamic therapy
Photothermal therapy
Online Access:https://doi.org/10.1186/s12951-021-00877-6

Internet

https://doi.org/10.1186/s12951-021-00877-6

Similar Items